Aurobindo Pharma
Aurobindo Pharma
Key Stats (Trailing)
52W Range
₹ 960 - 1593
MCap
₹ 72061 Cr
Volume
32 k
Div. Yield
0.4 %
Dividend
₹ 4.5
EPS
₹ 54.2
CEPS
₹ 80.1
PE Ratio
20.1
PEG
0.3
P/CE
13.6
EV/Net Sales
2.2
EV/EBITDA
10
EV/CE
1.8
P/S
2.2
P/B
2.1
Book NAV/Share
₹ 509.4
Sales Growth
16.7 %
EBITDA Growth
59.6 %
EBIT Growth
69.6 %
PAT Growth
64.4 %
EPS Growth
64.6 %
ROA
7.6 %
ROE
11.2 %
ROCE
13.8 %
D/E
0.2
Current Ratio
2
Quick Ration
1.1
Interest Cover
16.1
EBITDA Margin
9.8 %
Pre-tax Margin
7.3 %
PAT Margin
5.3 %
Tax Rate
27.7 %
Cash Profit Margin
7.9 %
Asset Turnover
1.4
Sales/Fixed Asset
2.8
Working Capital/Sales
5.2
Receivable Days
29
Payable Days
134
Inventory Days
56
Revenue
in ₹ Crores
EPS
in ₹
Margin
Annual P&L
in Crores
Revenue (TTM)
30,295
Operating Profit (TTM)
7,116
PAT (TTM)
3,600
EPS (in Rs.) (TTM)
62
Balance Sheet
in Crores
Cash & Bank Balance (2024)
6,278
Inventories (2024)
9,808
Total Debt (2024)
6,315
Book Value (in Rs.) (2024)
510
Cash Flow
in Crores
CF Operating Activities(2024)
2,435
CF Investing Activities (2024)
-4,256
CF Financing Activities (2024)
801
Net Cash Flow (2024)
-1,021
Valuation
P/E (2024)
20.1
P/B (2024)
2.1
EV/Sales (2024)
2.2
EV/EBITDA (2024)
10.0
Shareholding
Growth
Net Sales (2024)
17 %
Core EBITDA (2024)
60 %
PAT (2024)
65 %
EPS (2024)
65 %
Performance
ROA (2024)
8 %
ROE (2024)
12 %
ROCE (2024)
14 %
Asset Turnover (2024)
1.4
Financial Stability
Total Debt / Equity (2024)
0.2
Current Ratio (2024)
2.0
Quick Ratio (2024)
1.1
Interest Cover (2024)
16.1
Peers
by Market Cap in ₹ Crores
DCF Value
Reverse DCF
No related articles found !!!